Novel dicationic, heterocyclic triaryl compounds are useful in the treatment of microbial infections, such as
Trypanosoma brucei rhodesiense
infection and
Plasmodium falciparum
infection. These compounds are accordingly useful in treating second-stage human African trypanosomiasis. Pharmaceutical formulations comprising these compounds can be used in methods of treating microbial infections.
新型二元离子、杂环三芳基化合物可用于治疗微
生物感染,例如Trypanosoma brucei rhodesiense感染和Plasmodium falciparum感染。因此,这些化合物可用于治疗第二阶段的人类非洲锥虫病。包含这些化合物的药物制剂可用于治疗微
生物感染的方法中。